Mukka Proteins [MUKKA] vs Britannia Industries [BRITANNIA] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Mukka Proteins Ltd. wins in 6 metrics, Britannia Industries Ltd. wins in 13 metrics, with 0 ties. Britannia Industries Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Mukka Proteins Ltd. | Britannia Industries Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 15.95 | 57.14 | Mukka Proteins Ltd. |
| Price-to-Book Ratio | 1.58 | 36.97 | Mukka Proteins Ltd. |
| Debt-to-Equity Ratio | 131.93 | 58.42 | Britannia Industries Ltd. |
| PEG Ratio | -1.56 | 2.04 | Britannia Industries Ltd. |
| EV/EBITDA | 11.91 | 40.06 | Mukka Proteins Ltd. |
| Profit Margin (TTM) | 3.11% | 12.84% | Britannia Industries Ltd. |
| Operating Margin (TTM) | 6.34% | 18.02% | Britannia Industries Ltd. |
| EBITDA Margin (TTM) | 6.34% | 18.02% | Britannia Industries Ltd. |
| Return on Equity | 10.18% | 49.73% | Britannia Industries Ltd. |
| Return on Assets (TTM) | 4.32% | 24.65% | Britannia Industries Ltd. |
| Free Cash Flow (TTM) | $-1.39B | $21.06B | Britannia Industries Ltd. |
| Dividend Yield | N/A | 2.57% | N/A |
| 1-Year Return | -26.27% | -5.55% | Britannia Industries Ltd. |
| Price-to-Sales Ratio (TTM) | 0.50 | 7.34 | Mukka Proteins Ltd. |
| Enterprise Value | $12.94B | $1,393.29B | Britannia Industries Ltd. |
| EV/Revenue Ratio | 0.89 | 7.41 | Mukka Proteins Ltd. |
| Gross Profit Margin (TTM) | 13.19% | 42.28% | Britannia Industries Ltd. |
| Revenue per Share (TTM) | $48 | $781 | Britannia Industries Ltd. |
| Earnings per Share (Diluted) | $1.50 | $100.28 | Britannia Industries Ltd. |
| Beta (Stock Volatility) | 0.17 | 0.56 | Mukka Proteins Ltd. |
Mukka Proteins Ltd. vs Britannia Industries Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Mukka Proteins Ltd. | -2.18% | -3.64% | -8.54% | 0.73% | -13.71% | -8.73% |
| Britannia Industries Ltd. | 0.51% | -2.20% | -12.13% | -13.58% | -13.38% | -15.30% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Mukka Proteins Ltd. | -26.27% | -46.06% | -46.06% | -46.06% | -46.06% | -46.06% |
| Britannia Industries Ltd. | -5.55% | 11.82% | 49.16% | 276.68% | 2,238.89% | 3,482.89% |
Performance & Financial Health Analysis: Mukka Proteins Ltd. vs Britannia Industries Ltd.
| Metric | MUKKA | BRITANNIA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹7.18B | ₹1.38T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 303,019 | 434,599 |
| 90 Day Avg. Volume | 307,229 | 429,134 |
| Last Close | ₹21.96 | ₹5,090.00 |
| 52 Week Range | ₹18.27 - ₹32.80 | ₹5,035.00 - ₹6,336.00 |
| % from 52W High | -33.05% | -19.67% |
| All-Time High | ₹56.56 (Jul 15, 2024) | ₹6,469.90 (Sep 30, 2024) |
| % from All-Time High | -61.17% | -21.33% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 1.16% | 0.08% |
| Quarterly Earnings Growth | -0.10% | 0.17% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.13% |
| Operating Margin (TTM) | 0.06% | 0.18% |
| Return on Equity (TTM) | 0.10% | 0.50% |
| Debt to Equity (MRQ) | 131.93 | 58.42 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹15.12 | ₹155.00 |
| Cash per Share (MRQ) | ₹1.76 | ₹38.22 |
| Operating Cash Flow (TTM) | ₹-1,276,140,000 | ₹27.29B |
| Levered Free Cash Flow (TTM) | ₹464.59M | ₹21.79B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.57% |
| Last 12-Month Dividend | N/A | ₹148.50 |
Valuation & Enterprise Metrics Analysis: Mukka Proteins Ltd. vs Britannia Industries Ltd.
| Metric | MUKKA (Apr 22, 2026) | BRITANNIA (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 15.95 | 57.14 |
| Forward P/E | N/A | 47.94 |
| PEG Ratio | -1.56 | 2.04 |
| Price to Sales (TTM) | 0.50 | 7.34 |
| Price to Book (MRQ) | 1.58 | 36.97 |
| Market Capitalization | ||
| Market Capitalization | ₹7.18B | ₹1.38T |
| Enterprise Value | ₹12.94B | ₹1.39T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.89 | 7.41 |
| Enterprise to EBITDA | 11.91 | 40.06 |
| Risk & Other Metrics | ||
| Beta | 0.17 | 0.56 |
| Book Value per Share (MRQ) | ₹15.12 | ₹155.00 |
Financial Statements Comparison: Mukka Proteins Ltd. vs Britannia Industries Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | MUKKA (2025) | BRITANNIA (2025) |
|---|---|---|
| Revenue/Sales | 9.80B | 175.35B |
| Cost of Goods Sold | 8.00B | 106.74B |
| COGS % of Revenue | 81.6% | 60.9% |
| Gross Profit | 1.80B | 68.61B |
| Gross Margin | 18.4% | 39.1% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 815.67M | 28.74B |
| Operating Margin | 8.3% | 16.4% |
| EBITDA | 1.00B | 33.18B |
| EBITDA Margin | 10.2% | 18.9% |
| Pre-Tax Income | 602.66M | 29.27B |
| Pre-Tax Income % of Revenue | 6.1% | 16.7% |
| Income Tax | 121.69M | 7.49B |
| Income Tax % of Revenue | 1.2% | 4.3% |
| Net Income (Profit) | 480.97M | 21.78B |
| Profit Margin | 4.9% | 12.4% |
Balance Sheet & Liquidity Metrics
| Metric | MUKKA (2025) | BRITANNIA (2025) |
|---|---|---|
| Cash & Equivalents | 30.75M | 1.33B |
| Total Current Assets | 9.26B | 39.14B |
| Total Current Assets % of Revenue | 94.5% | 22.3% |
| Total Current Liabilities | 6.10B | 36.18B |
| Total Current Liabilities % of Revenue | 62.3% | 20.6% |
| Long-Term Debt | 41.40M | 7.32B |
| Long-Term Debt % of Revenue | 0.4% | 4.2% |
| Total Shareholders Equity | 4.57B | 43.81B |
| Retained Earnings | 2.26B | 40.36B |
| Retained Earnings % of Revenue | 23.1% | 23.0% |
| Property, Plant & Equipment | 451.97M | 27.35B |
Cash Flow Statement Comparison
| Metric | MUKKA (2025) | BRITANNIA (2025) |
|---|---|---|
| Operating Cash Flow | -1.28B | 27.29B |
| Operating Cash Flow % of Revenue | -13.0% | 15.6% |
| Capital Expenditures | -184.38M | -3.70B |
| Free Cash Flow | -1.39B | 21.06B |
| FCF Margin | -14.2% | 12.0% |
| Debt Repayment | N/A | -8.47B |
| Common Stock Repurchase | -25.27M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MUKKA | BRITANNIA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 300.00M | 240.87M |
| Float Shares | 80.16M | 117.57M |
| % Held by Insiders | 74.52% | 50.55% |
| % Held by Institutions | 0.00% | 25.42% |
| % Held by Public | 25.48% | 24.03% |
Dividend Analysis & Yield Comparison: Mukka Proteins Ltd. vs Britannia Industries Ltd.
| Metric | MUKKA | BRITANNIA |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹148.50 |
| Last 12-Month Dividend Yield | N/A | 2.57% |
| 3-Year Avg Annual Dividend | N/A | ₹73.50 |
| 3-Year Avg Dividend Yield | N/A | 1.42% |
| 3-Year Total Dividends | N/A | ₹220.50 |
| Ex-Dividend Date | N/A | Aug 04, 2025 |